Chemotherapy for patients with advanced lung cancer with interstitial lung disease: a prospective observational study.
Keigo KodaYasunori EnomotoYoichiro AoshimaYusuke AmanoShinpei KatoHirotsugu HasegawaTakashi MatsuiKoshi YokomuraEisuke MochizukiShun MatsuuraNaoki KoshimizuMeiko MoritaSuguru KojimaAyano WatanabeYoshiyuki OyamaMasaki IkedaHideki KusagayaTomohiro UtoJun SatoShiro ImokawaMasato KonoDai HashimotoYosuke KamiyaMikio ToyoshimaKazuhiro AsadaMasako MoritaMasashi MikamoHideki YasuiHironao HozumiMasato KarayamaYuzo SuzukiKazuki FuruhashiTomoyuki FujisawaNoriyuki EnomotoYutaro NakamuraNaoki InuiTakafumi SudaPublished in: Therapeutic advances in chronic disease (2022)
AE-ILD during chemotherapy is a frequent complication among patients with lung cancer with ILD, particularly those with lower %FVC. Conversely, even in this population, passable treatment response can be expected.